ONCY Oncolytics Biotech Inc
Company Analysis
Latest News
🔴 Oncolytics Biotech is trading 5% down today with no clear catalyst
Oncolytics Biotech is trading 5% down at $0.80, with no clear company-specific catalyst identified for September 8, 2026. - The broader market is also weaker:...
🟢 Oncolytics Biotech is trading 5% up today as XBI rises 2.75%
Oncolytics Biotech is trading at $0.88, up 5.02%, with biotech-sector momentum the likeliest driver. • No fresh company-specific announcement was identified...
🟢 Oncolytics Biotech is trading 5.4% up today amid broader biotech-sector gains
Oncolytics Biotech is trading 5.4% up at $0.84, with the move most consistent with broader risk appetite. - Biotechnology is up 2.02%, while major U.S....
Oncolytics Aligns with FDA on Pivotal Study Design for Colorectal Cancer Drug
Oncolytics Biotech announced it received written feedback from the U.S. Food and Drug Administration (FDA) aligning on a registrational path for its drug,...
🟢 Oncolytics Biotech is trading 5.67% up today after investors digested second-quarter results
Oncolytics Biotech is trading 5.67% up now at $0.85 after investors digested its second-quarter results, published August 12, 2026. - Reported a $9.44 million...
Oncolytics Biotech Inc Q2 2026 Earnings Preview: What Analysts Expect on August 14, 2026
For the second quarter of 2026, analysts expect Oncolytics Biotech to report an EPS of -$0.06 on zero revenue, with the current $1.45 share price trading...
🔴 Oncolytics Biotech is trading 5% down today
Oncolytics Biotech is trading 5.13% down at $0.76 after no clear company-specific catalyst emerged for the August 10, 2026 decline. - July’s FDA Fast Track...
🟢 Oncolytics Biotech is trading 5.8% up today amid a broad biotech sector and market rally
Oncolytics Biotech is trading 5.8% up at $0.82 amid a strong risk-on session in U.S. equities and a broad biotech sector rally. • The move aligns with a wider...
Receives FDA Fast Track Designation for Pelareorep in Anal Cancer Treatment
Oncolytics Biotech announced that its investigational immunotherapy, pelareorep, in combination with a checkpoint inhibitor, has been granted Fast Track...
🟢 Oncolytics Biotech Inc is trading 7.82% up in pre-market
ONCY is trading at $0.92, up 7.82% in pre-market.
🔴 Oncolytics Biotech is trading 5% down today amid weakness in small-cap biotech stocks
Oncolytics Biotech is trading at $0.86 (-5.03%) today, moving lower in alignment with a weak tape for small-cap biotech names despite a lack of...
Oncolytics to Meet FDA on Registrational Pathway for REO 033 Colorectal Cancer Trial
Oncolytics Biotech provided a clinical and regulatory update for its REO 033 study, which evaluates its drug pelareorep for second-line metastatic colorectal...
🟢 Oncolytics Biotech is trading 10.1% up today on speculative momentum
Oncolytics Biotech is trading 10.1% up at $1.02 today, driven by speculative interest and trading momentum despite a lack of fresh company-specific news or...
🟢 Oncolytics Biotech is trading 5.9% up today, extending a volatile stretch despite no fresh news
Oncolytics Biotech is trading at $0.94 (5.9% up) in pre-market, extending a volatile stretch that included a double-digit gain on July 9 followed by a pullback...
🟢 Oncolytics Biotech is trading 5.9% up today in after-hours trading
Oncolytics Biotech is trading at $0.94 (up 5.9%) in after-hours trading despite a lack of fresh company-specific news or regulatory updates. • The stock has...
🟢 Oncolytics Biotech is trading 10.0% up
Oncolytics Biotech is trading at $0.87, up 10.0% from a comparison close of $0.79 during regular trading. This is a price-action follow-up, so a separate...
🟢 ONCY is trading 6% up today in an after-hours rebound
ONCY is trading at $0.84 (+6%) in after-hours trading, staging a rebound following a weak regular session. • The stock closed at $0.79 on July 8, with the...
🔴 ONCY is trading 5.2% down today amid technical weakness and risk-off sentiment
ONCY is trading 5.2% down today at $0.83 as the stock continues to face pressure from negative technical indicators and broader market trends. • Recent...
🔴 ONCY is trading 5.03% down today with no clear company-specific catalyst
ONCY is trading at $0.90 (-5.03%) following a sharp intraday selloff despite a lack of company-specific news or regulatory updates. • No earnings releases,...